Radiation Oncology/Therapy: Page 308

Varian reports Q2 sales growth
By AuntMinnie.com staff writers
Radiation therapy firm Varian Medical Systems reported decreases in revenue and net earnings for the second quarter of 2009.
April 29, 2009
FDA clears proton positioning system
By AuntMinnie.com staff writers
Radiopharmaceutical firm Ion Beam Applications and partner ProCure Treatment Centers have announced that the U.S. Food and Drug Administration has cleared a patient positioning system for proton therapy systems marketed by the companies.
April 28, 2009
Report: U.S. cancer cases will grow by 45% in 20 years
By AuntMinnie.com staff writers
A new report published today projects that the number of new cancer cases in the U.S. will grow by 45% over the next 20 years, with a "dramatic spike" predicted among elderly and minority populations.
April 28, 2009
Varian launches brachytherapy applicator
By AuntMinnie.com staff writers
Radiation therapy firm Varian Medical Systems has introduced a new brachytherapy applicator set for increased treatment precision for patients with bronchial cancer.
April 27, 2009
Nucletron adds to sales in 2008
By AuntMinnie.com staff writers
Radiation oncology firm Nucletron credited a renewed focus on brachytherapy treatment and an expanding product line in external-beam treatment planning software for sales growth in 2008.
April 23, 2009
Trastuzumab + RT = no cardiac risk in breast cancer
By AuntMinnie.com staff writers
Women diagnosed with early-stage HER2-positive breast cancer can breathe a sigh of relief: Concurrent treatment with radiation therapy (RT) and adjuvant trastuzumab following chemotherapy with doxorubicin and cyclophosphamide does not increase the risk of adverse cardiac events.
April 23, 2009
Endometrial cancer radiation treatment increases second cancer risk
By Cynthia E. Keen
In 2008, 41,800 women were diagnosed with endometrial cancer, and approximately one-third of them had radiation therapy to treat the disease. But radiation therapy for women with early-stage, low-risk endometrial cancer has been controversial due to the possible risk of developing additional cancers -- a concern recently verified by Michigan researchers.
April 23, 2009
Elekta nabs U.S. GPO contract
By AuntMinnie.com staff writers
Swedish oncology firm Elekta has won a contract with one of the largest nonprofit group purchasing organizations (GPO) in the U.S. for its oncology delivery systems.
April 22, 2009
New technology spurs investment in brachytherapy
By Marvin Burns
The U.S. market for brachytherapy products should exceed $1 billion in the next five years, driven by the introduction of new products that allow accelerated treatment for cancer patients after surgery. The worldwide market could grow even more rapidly, according to this analysis from market research firm Bio-Tech Systems.
April 22, 2009
2004 09 29 16 20 24 706
RaySearch, Philips launch SmartArc
By AuntMinnie.com staff writers
Swedish radiation therapy software developer RaySearch Laboratories said that partner Philips Healthcare has received U.S. Food and Drug Administration 510(k) clearance for its SmartArc treatment planning software.
April 21, 2009
TomoTherapy to restate earnings
By AuntMinnie.com staff writers
Radiation therapy firm TomoTherapy said it will restate financial results for its 2008 fiscal year due to errors related to accounting for income taxes.
April 21, 2009
MRI analysis predicts brain cancer survival
By AuntMinnie.com staff writers
Researchers at the University of Michigan Comprehensive Cancer Center in Ann Arbor are using a new MRI-based analysis method to predict patient survival as early as one week after brain tumor treatment.
April 21, 2009
Previous Page
Page 308 of 468
Next Page